Indian Oil Majors Refining Margins Stay Within Normal Range Amid Hormuz Disruption Data Shows Foreign Portfolio Investors Voice Concerns Over Rupee Depreciation and Dwindling Returns at Hong Kong Conference NASCAR Champion Kyle Busch Dies at 41 from Pneumonia and Sepsis Complications Jim Cramer Highlights Four Portfolio Stocks as Potential Opportunities Beyond AI AI Investment Surge Supports US Earnings Amid Economic Deceleration UK Heatwave Drives Surge in Fan and Cooling Product Sales AJG Q1 2026 Earnings EPS Falls Just Short of Consensus Shares Edge Higher IMMX Q1 2026 Earnings Narrowed Loss as Biotech Advances Oncology Pipeline SOJE Q1 2026 Earnings Southern Company Beats EPS Estimates as Utility Operations Remain Stable SNY Q1 2026 Earnings EPS Beat on Strong Operational Execution Amid Broader Headwinds BG Q1 2026 Earnings Earnings Surge 103 Above Estimates as Agribusiness Strength Outpaces Expectations RBBN Q1 2026 Earnings EPS Beat Amidst Challenging Telecom Environment TRG Latin America Acquisitions Corp Units TRGSU Holds Steady Near Trust Value as Market Awaits Business Combination IP Strategy Holdings Inc IPST Faces Sharp Decline Testing Key Support Levels The Honest Company HNST Edges Higher as Stock Tests Key Resistance Near 385 V2X Inc VVX Gains 265 Approaches Key Resistance at 7973 Enviri Corporation NVRI Surges 578 as Shares Test Key Resistance Zone AEW Double or Nothing 2026 Match Card Highlights and Streaming Details Announced Live Oak Bancshares LOB Q1 2026 Earnings Strong EPS Beat as Net Interest Margins Hold Steady BGM Group Ltd BGM Shows Modest Uptick as Stock Tests Key Resistance Level Manhattan Bridge Capital LOAN Slides 118 as Shares Approach Key Support Zone AZZ Inc AZZ Consolidates Near Resistance After Slight Decline UTStarcom Holdings UTSI Surges 575 as Shares Test Key Resistance at 298 Fresenius Medical Care FMS Posts Modest Gain as Stock Consolidates Within Key Range Mueller Water Products MWA Edges Higher as Support Holds Steady NexPoint Diversified Real Estate Trust NXDT Rallies 54 Key Levels to Watch NeuroSense Therapeutics NRSN Edges Higher Testing Resistance at 095